Stock FAQs

why is nnox stock up today

by Marielle Schulist Published 3 years ago Updated 2 years ago
image

Shares of Nano-X Imaging ( NNOX 4.61% ), or simply called Nanox, continued jumping higher on Tuesday after the company announced that it's opened a new facility to aid in the production of its medical devices. The stock was already up roughly 20% following the release of financial results last week.Apr 5, 2022

How much is a share of nnox worth?

Apr 13, 2022 · View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations. Get daily stock ideas top-performing Wall Street analysts.

How can I get the latest news about nnox?

Why Nano-X Imaging Zoomed 15% Higher Today. Revenue has started to flow into ambitious next-generation medical technology specialist Nano-X Imaging (NASDAQ: NNOX), also known as Nanox. Investors ...

What is Nano-X imaging's (nnox) stock price?

Mar 30, 2022 · 2 brokers have issued 1-year price objectives for Nano-X Imaging's shares. Their forecasts range from $52.00 to $52.00. On average, they expect Nano-X Imaging's stock price to reach $52.00 in the next year. This suggests a possible upside of …

What are Wall Street's target price targets for Nano-X imaging's stock?

Apr 14, 2022 · Nano X Imaging Ltd NASDAQ Updated Apr 14, 2022 11:49 PM. NNOX 11.56 0.06 (0.52%). Post-Market 0.13 (1.13%)

image

Is NNOX a buy now?

According to the issued ratings of 2 analysts in the last year, the consensus rating for Nano-X Imaging stock is Buy based on the current 1 hold rating and 1 buy rating for NNOX.

Is NNOX a good stock?

The financial health and growth prospects of NNOX, demonstrate its potential to underperform the market. It currently has a Growth Score of B. Recent price changes and earnings estimate revisions indicate this stock lacks momentum and would be a lackluster choice for momentum investors.

Did NNOX get FDA approval?

Nano-X Imaging (NASDAQ:NNOX) announced that Zebra Medical Vision has been granted the eighth 510K FDA clearance for its Coronary Artery Calcium (CAC) solution. Nano-X (NNOX) is in agreement to acquire Zebra Medical Vision in an all-stock deal worth up to $200 million.Sep 27, 2021

How many shares of NNOX are there?

Share StatisticsAvg Vol (3 month) 3732.87kShares Outstanding 551.79MImplied Shares Outstanding 6N/AFloat 835.78M% Held by Insiders 114.66%7 more rows

What does NNOX company do?

We are a global company planning mass deployment of imaging systems with the goal to drive early detection preventive healthcare as a new standard of global care.

Is NNDM stock a buy?

According to Wallet Investor, it currently suggests NNDM is a stock worth investing in. This particular website updates itself often, keeping up with the current trends going on in the New York Stock Exchange. The long-term projections suggest 2025 and 2027 share promising return values for the investment.Mar 21, 2022

Is Nano-X Imaging a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nano-X Imaging in the last twelve months. There are curr...

When is Nano-X Imaging's next earnings date?

Nano-X Imaging is scheduled to release its next quarterly earnings announcement on Thursday, March 31st 2022. View our earnings forecast for Nano-...

How can I listen to Nano-X Imaging's earnings call?

Nano-X Imaging will be holding an earnings conference call on Thursday, March 31st at 8:30 AM Eastern. Interested parties can register for or liste...

How were Nano-X Imaging's earnings last quarter?

Nano-X Imaging Ltd. (NASDAQ:NNOX) issued its quarterly earnings data on Tuesday, November, 16th. The company reported ($0.28) EPS for the quarter,...

What price target have analysts set for NNOX?

2 analysts have issued 12-month price targets for Nano-X Imaging's shares. Their forecasts range from $52.00 to $52.00. On average, they expect Nan...

Who are Nano-X Imaging's key executives?

Nano-X Imaging's management team includes the following people: Mr. Ran Poliakine , Founder, Chairman & CEO (Age 53) Mr. Itzhak Maayan , Chief...

Who are some of Nano-X Imaging's key competitors?

Some companies that are related to Nano-X Imaging include Koninklijke Philips (PHG) , Hologic (HOLX) , Butterfly Network (BFLY) , Hyperfine (HY...

What other stocks do shareholders of Nano-X Imaging own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nano-X Imaging investors own include NVIDIA (NVDA) , Adva...

When did Nano-X Imaging IPO?

(NNOX) raised $100 million in an initial public offering on Friday, August 21st 2020. The company issued 5,900,000 shares at $16.00-$18.00 per shar...

What Percentage Of Nano-X Imaging Ltd. (NASDAQ:NNOX) Shares Do Insiders Own?

Nano-X Drops After FDA Seeks More Data on New X-Ray System

If you want to know who really controls Nano-X Imaging Ltd. ( NASDAQ:NNOX ), then you'll have to look at the makeup of...

Nano-X Imaging Ltd. (NNOX) Q2 2021 Earnings Call Transcript

Nano-X Imaging fell after the FDA requested additional information concerning the company's application for its portable X-ray system.

Why Nanox Stock Plunged Today

On today's call, we will hear from Ran Poliakine, chairman of the board and chief executive officer; and Itzhak Maayan, chief financial officer. The definitive agreement with USARAD may not be entered into on terms or in the time frame currently contemplated.

3 High-Growth Healthcare Stocks to Buy in August

Shares of medical-imaging company Nano-X Imaging (NASDAQ: NNOX), commonly referred to as Nanox, plunged on Tuesday following the release of financial results for the second quarter of 2021. Rather, the company also announced a shuffling with the management team which tends to make investors jumpy. As of 12:15 p.m.

Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead

If you're looking for stocks that can provide life-changing returns, the healthcare sector has exactly what want. Laboratory-to-market synthetic biology, or synbio, platforms are a dime a dozen these days, but Amyris stands head and shoulders above the rest.

3 Healthcare Stocks That Could Make You Rich

Apple (NASDAQ: AAPL), Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) (whose Google unit is the "G" in FAANG), Amazon.com (NASDAQ: AMZN), and Facebook (NASDAQ: FB) -- rank among the top 10 biggest companies in the world. Only Netflix (NASDAQ: NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.

Is Nano-X Imaging a buy right now?

If you're looking to take that same path, healthcare stands out as one of the biggest market opportunities around. Here are three healthcare stocks that could make you rich over the next decade. Beam Therapeutics (NASDAQ: BEAM) is the pioneering leader in genomic base editing.

What stocks does MarketBeat like better than Nano-X Imaging?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nano-X Imaging in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock.

Are investors shorting Nano-X Imaging?

Wall Street analysts have given Nano-X Imaging a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Nano-X Imaging wasn't one of them.

When is Nano-X Imaging's next earnings date?

Nano-X Imaging saw a increase in short interest in the month of August. As of August 13th, there was short interest totaling 4,820,000 shares, an increase of 16.7% from the July 29th total of 4,130,000 shares. Based on an average trading volume of 1,210,000 shares, the short-interest ratio is currently 4.0 days.

How were Nano-X Imaging's earnings last quarter?

Nano-X Imaging is scheduled to release its next quarterly earnings announcement on Monday, November 8th 2021.#N#View our earnings forecast for Nano-X Imaging.

What price target have analysts set for NNOX?

Nano-X Imaging Ltd. (NASDAQ:NNOX) announced its quarterly earnings data on Tuesday, August, 10th. The company reported ($0.28) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.23) by $0.05.#N#View Nano-X Imaging's earnings history.

Who are some of Nano-X Imaging's key competitors?

5 Wall Street analysts have issued twelve-month price objectives for Nano-X Imaging's stock. Their forecasts range from $52.00 to $67.00. On average, they anticipate Nano-X Imaging's stock price to reach $61.33 in the next twelve months.

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9